Skip to main content

tobramycin (Bramitob®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name tobramycin (Bramitob®)
Formulation 300 mg/4 ml nebuliser solution
Reference number 54
Indication

Management of chronic pulmonary infection due to pseudomonas aeruginosa in patients with cystic fibrosis aged 6 and older

Company Chiesi Ltd
BNF chapter Infections
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 04/08/2009
Follow AWTTC: